The Molecular Pathology of Non-Malignant Haematological Disease - Takeaways - MDSpire

The Molecular Pathology of Non-Malignant Haematological Disease

  • By

  • A. D. Blann

  • R. G. Dunn

  • May 22, 2026

  • 0 min

Share

  • 1

    Molecular pathology has significantly advanced the diagnosis and management of hematological disorders, particularly hemoglobinopathies.

  • 2

    Hemoglobinopathies, including sickle cell disease and thalassemia, are the most prevalent non-malignant hematological disorders globally.

  • 3

    The Global Burden of Disease study reported over 104,600 deaths due to hemoglobinopathies and hemolytic anemias in 2017.

  • 4

    G6PD deficiency and other hematological diseases also contribute to global morbidity, with significant years lived with disability.

  • 5

    Advancements in molecular genetics have clarified the genetic basis of hemoglobinopathies, aiding in targeted therapeutic options.

Original Source(s)

The Molecular Pathology of Non-Malignant Haematological Disease

  • by A. D. Blann, R. G. Dunn

  • May 22, 2026

Related Content

Novel PTRH2::ALK Fusion in ALK-positive Histiocytosis Presenting as a Liver Abscess in an Infant: A Case Study

Temporal variation in nutritional status and preoperative anemia among patients with retroperitoneal soft tissue sarcoma: a retrospective longitudinal cohort study

Merging evans syndrome with mucopolysaccharidosis type II: a case report